Jolene Bostwick, PharmD
Dr. Bostwick is the Assistant Dean for Co-Curriculum and Professional Development and Clinical Professor of Pharmacy at the University of Michigan College of Pharmacy. She received her PharmD degree from the University of Michigan College of Pharmacy. Following graduation, she completed a specialty residency in psychiatric pharmacy with Kaiser Permanente in Denver, CO. She practiced as a psychiatric pharmacist for 15 years, developing pharmacy services in inpatient and outpatient psychiatry, before transitioning into her current administrative role. Past administrative roles include serving as Associate Chair of the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy. She is the Course Director of Patient Care and Communication (P506) and co-Director of Well-being for Professional Success (P507). In addition to the didactic teaching of pharmacy students, Dr. Bostwick serves as a preceptor for pharmacy students and residents. She is an active member of the College of Psychiatric and Neurologic Pharmacists (CPNP), currently serving as the Annual Meeting Director and has served as past Chair of the Program and Student Committees. Dr. Bostwick is also a member of the Rho Chi Pharmacy Honor Society and has published over 70 articles and book chapters, largely focusing in psychiatry, teaching, and the role of psychiatric pharmacists.
Oversight of Co-curricular Program
Oversight of CoP Student Organizations
Professional/personal student guidance and well-being
Student Professional Concern Note Process
Leadership Scholars Program Lead
Metabolic monitoring in individuals treated with second generation antipsychotic medications
Impact of pharmacy services in psychiatry
Student mental health and well-being
Harris SC, Bostwick JR, Werremeyer AB, Goldstone LW, Cates ME, Caley CF. Wellness and stigma: pharmacy’s ongoing conflict. Am J Pharm Educ. 2021, in press.
Funk MC, Beach SR, Bostwick JR, Celano CM, Hasnain M, Pandurangi A, Khandai AC, Taylor A, Levenson JL, Riba M, Kovacs RJ. QTc prolongation and psychotropic medications. Am J Psychiatry. 2020;177(3):273-4.
Chow CL, Kadouh NK, VandenBerg AM, Bostwick JR. Akathisia in newer second-generation antipsychotic drugs: a review of current evidence. Pharmacotherapy. 2020;40(6):565-574.
Silvia RJ, Lee KC, Bostwick JR, Cobb CD, Goldstone LW, Moore TD, Payne GH, Ho JL. Assessment of the current practice of psychiatric pharmacists in the United States. Ment Health Clin [Internet]. 2020;10(6):346-53.
Werremeyer A, Bostwick J, Cobb C, Moore TD, Park SH, Price C, et al. Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin [Internet]. 2020;10(6):358-80. DOI: 10.9740/mhc.2020.11.358
Bixby AL, VandenBerg A, Bostwick JR. Therapeutic controversies with serotonin reuptake inhibitors: to bleed or not to bleed? Annals of Pharmacotherapy. 2018 Aug 6:1060028018794005. doi: 10.1177/1060028018794005.
Dopheide J, Bostwick JR, Goldstone L, Thomas K, Nemire R, Gable K, Cates M, Caballero J, Smith T, Bainbridge J. Curriculum in psychiatry and neurology for pharmacy programs. American Journal of Pharmaceutical Education. 2017;81(7): Article 5925.
Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Annals of Pharmacotherapy. 2013;47(10):1330-41. doi: 10.1177/1060028013501994
Jasiak NM, Bostwick JR. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Annals of Pharmacotherapy. 2014;48(12):1620-8. doi: 10.1177/1060028014550645
Lee J, Dalack GW, Casher MI, Eappen SA, Bostwick JR. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention. Journal of Clinical Pharmacy and Therapeutics 2016;41(2):209-13. doi: 10.1111/jcpt.12368
Farhat NM, Bostwick JR, Rockafellow SD. Improving PGY2 ambulatory care residency training in psychiatry. Journal of Pharmacy Practice. 2017 Jan 1: 897190017729598. doi: 10.1177/0897190017729598. [Epub ahead of print].
Thomas SJ, Shin M, McInnis MG, Bostwick JR. Monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Pharmacotherapy. 2015;35(4):433-9. doi: 10/1002/phar.1576.
Bostwick JR, Leung G, Smith TL, Ahmed U, Bainbridge JL, Peyronnet J. Survey highlights the need to expand offerings of introductory pharmacy practice experiences in psychiatry and neurology: benefits and example experiences. Mental Health Clinician [Internet]. 2018;8(1):7-13. DOI: 10.9740/mhc.2018.01.007.